Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New navigation items were added for How to Read a Study Record, Common Questions, and How to Join a Study; a recruitment status message indicates no participants are being sought; the Intervention label was changed to Intervention/Treatment and the revision version updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:11:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's Revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the page's metadata/content.
    Difference
    0.0%
    Check dated 2026-06-05T21:43:32.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The revision indicator updated from v3.5.3 to v3.5.4, signaling a new page release. This reflects an internal update to the page rather than a substantive change to study information.
    Difference
    0.0%
    Check dated 2026-05-15T15:35:00.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3 in the site footer, reflecting a minor ClinicalTrials.gov software/content-display update rather than any change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:35:53.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2. No visible changes to the study record content are indicated.
    Difference
    0.0%
    Check dated 2026-04-17T02:44:36.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    B-cell chronic lymphocytic leukemia was added to the list of conditions described on the study page.
    Difference
    0.1%
    Check dated 2026-04-02T15:40:51.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.